A Prospective Trial of Varenicline and Incentives for E Cigarette Cessation in Adults Who Co Use Cannabis

Sponsor:

National Cancer Institute

Sponsor Study ID:

R37CA237245

CTO #:

104079

NCT Number:

NCT06688539

Phase:

IV

Protocol Type:

Prevention

Age Group:

Adults

Disease Sites:

Study Objectives:

Compare rates of 7-day biochemically-confirmed e-cigarette abstinence with cigarette abstinence rates from the parent R37 co-use sample (as a historical controls). Assess changes in cannabis use during e-cigarette cessation treatment among the new sample of participants enrolled in this extension. Assess for a dose-dependent impact of cannabis co-use severity on e-cigarette cessation.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)